Global Oncology Clinical Trial Market 2021-2025
SKU ID :TNV-19820764 | Published Date: 24-Dec-2021 | No. of pages: 120Description
TOC
• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Design
o Market segments
o Comparison by Design
o Interventional - Market size and forecast 2020-2025
o Observational - Market size and forecast 2020-2025
o Expanded Access - Market size and forecast 2020-2025
o Market opportunity by Design
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o F. Hoffmann-La Roche Ltd.
o Icon Plc
o IQVIA Holdings Inc.
o Medpace Holdings Inc.
o Merck and Co. Inc.
o Novartis AG
o Novotech (Australia) Pty Ltd.
o Parexel International Corp.
o Pivotal S.L.U
o Syneos Health Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Design - Market share 2020-2025 (%)
• 22: Comparison by Design
• 23: Interventional - Market size and forecast 2020-2025 ($ million)
• 24: Interventional - Year-over-year growth 2020-2025 (%)
• 25: Observational - Market size and forecast 2020-2025 ($ million)
• 26: Observational - Year-over-year growth 2020-2025 (%)
• 27: Expanded Access - Market size and forecast 2020-2025 ($ million)
• 28: Expanded Access - Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by Design
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2020-2025 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2020-2025 ($ million)
• 34: North America - Year-over-year growth 2020-2025 (%)
• 35: Europe - Market size and forecast 2020-2025 ($ million)
• 36: Europe - Year-over-year growth 2020-2025 (%)
• 37: Asia - Market size and forecast 2020-2025 ($ million)
• 38: Asia - Year-over-year growth 2020-2025 (%)
• 39: ROW - Market size and forecast 2020-2025 ($ million)
• 40: ROW - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: F. Hoffmann-La Roche Ltd. - Overview
• 50: F. Hoffmann-La Roche Ltd. - Business segments
• 51: F. Hoffmann-La Roche Ltd. - Key offerings
• 52: F. Hoffmann-La Roche Ltd. - Key customers
• 53: F. Hoffmann-La Roche Ltd. - Segment focus
• 54: Icon Plc - Overview
• 55: Icon Plc - Product and service
• 56: Icon Plc - Key offerings
• 57: Icon Plc - Key customers
• 58: Icon Plc - Segment focus
• 59: IQVIA Holdings Inc. - Overview
• 60: IQVIA Holdings Inc. - Business segments
• 61: IQVIA Holdings Inc. - Key offerings
• 62: IQVIA Holdings Inc. - Key customers
• 63: IQVIA Holdings Inc. - Segment focus
• 64: Medpace Holdings Inc. - Overview
• 65: Medpace Holdings Inc. - Business segments
• 66: Medpace Holdings Inc. - Key offerings
• 67: Medpace Holdings Inc. - Key customers
• 68: Medpace Holdings Inc. - Segment focus
• 69: Merck and Co. Inc. - Overview
• 70: Merck and Co. Inc. - Business segments
• 71: Merck and Co. Inc. - Key offerings
• 72: Merck and Co. Inc. - Key customers
• 73: Merck and Co. Inc. - Segment focus
• 74: Novartis AG - Overview
• 75: Novartis AG - Business segments
• 76: Novartis AG - Key offerings
• 77: Novartis AG - Key customers
• 78: Novartis AG - Segment focus
• 79: Novotech (Australia) Pty Ltd. - Overview
• 80: Novotech (Australia) Pty Ltd. - Product and service
• 81: Novotech (Australia) Pty Ltd. - Key offerings
• 82: Novotech (Australia) Pty Ltd. - Key customers
• 83: Novotech (Australia) Pty Ltd. - Segment focus
• 84: Parexel International Corp. - Overview
• 85: Parexel International Corp. - Product and service
• 86: Parexel International Corp. - Key offerings
• 87: Parexel International Corp. - Key customers
• 88: Parexel International Corp. - Segment focus
• 89: Pivotal S.L.U - Overview
• 90: Pivotal S.L.U - Product and service
• 91: Pivotal S.L.U - Key offerings
• 92: Pivotal S.L.U - Key customers
• 93: Pivotal S.L.U - Segment focus
• 94: Syneos Health Inc. - Overview
• 95: Syneos Health Inc. - Business segments
• 96: Syneos Health Inc. - Key offerings
• 97: Syneos Health Inc. - Key customers
• 98: Syneos Health Inc. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations
Tables & Figures
Companies
F. Hoffmann-La Roche Ltd., Icon Plc, IQVIA Holdings Inc., Medpace Holdings Inc., Merck and Co. Inc., Novartis AG, Novotech (Australia) Pty Ltd., Parexel International Corp., Pivotal S.L.U, Syneos Health Inc.
- PRICE
-
$2500$5000